MC

M.D.-Ph.D. Dr Gisela Mautner Mph, Mba, Facpe, Maicd, Fiidm, Cceo

Chief Executive Officer at Noxopharm Limited

Dr Gisela Mautner has a diverse range of work experience. Currently, they hold the position of Chief Executive Officer and Executive Director at Noxopharm Limited since February 2022. Dr Gisela is also a Non-Executive Director at Nyrada Inc. (ASX:NYR) since August 2022 and Australian Ice Racing since September 2022. Dr Mautner has been actively involved in MAPA Medical Affairs Professionals of Australasia, where they served as President from November 2019 to November 2021. Prior to that, they held the role of Vice President and Treasurer from January 2014 to November 2019 and is now Past President. Their extensive qualifications include MD-PhD, MPH, MBA, FACPE, MAICD, FIIDM, and CCEO.

Dr. Gisela Mautner, MD-PhD, MPH, MBA, FACPE, MAICD, FIIDM, CCEO has an extensive education history. Dr Gisela earned a Doctor of Medicine (MD) degree from the Technical University of Munich and a Doctor of Philosophy (PhD) degree in Medicine from Ludwig-Maximilians-Universität München. Additionally, they pursued further studies in the field of healthcare administration and management, earning a Master of Public Health (MPH) degree from the Harvard T.H. Chan School of Public Health. Dr. Mautner also holds a Master of Business Administration (MBA) degree from the Kellogg-WHU Executive MBA program. Their educational achievements demonstrate a combination of medical expertise and a strong foundation in healthcare administration and management.

Links

Timeline

  • Chief Executive Officer

    February, 2022 - present